GlaxoSmithKline au Grand-Duché de Luxembourg

GlaxoSmithKline Consumer Healthcare SA

Report an adverse event

For Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use (BCPH) of the Federal Agency for Medicines and Health Products (FAMHP) by following the procedure described on the website http://www.fagg-afmps.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. at the number +32 (0)10 85 85 00.

For Luxembourg: Please report adverse events to Ministère de la Santé du Grand-Duché de Luxembourg (Division de la Pharmacie et des Médicaments at fax number +35 (0)2 24795615 or by post) or to Centre Régional de Pharmacovigilance de Lorraine (fax number +33 (0)3 83 32 33 44 or crpv@chu-nancy.fr) or to GlaxoSmithKline Pharmaceuticals s.a./n.v. at number +32 (0)10 85 85 00.